BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35349635)

  • 21. Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort.
    Maponga TG; McNaughton AL; van Schalkwyk M; Hugo S; Nwankwo C; Taljaard J; Mokaya J; Smith DA; van Vuuren C; Goedhals D; Gabriel S; Andersson MI; Preiser W; van Rensburg C; Matthews PC
    J Infect; 2020 Jul; 81(1):121-130. PubMed ID: 32360882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.
    Singh KP; Crane M; Audsley J; Avihingsanon A; Sasadeusz J; Lewin SR
    AIDS; 2017 Sep; 31(15):2035-2052. PubMed ID: 28692539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
    Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
    AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
    Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
    PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.
    Khalili M; King WC; Kleiner DE; Jain MK; Chung RT; Sulkowski M; Lisker-Melman M; Wong DK; Ghany M; Sanyal A; Sterling RK
    Clin Infect Dis; 2021 Nov; 73(9):e3275-e3285. PubMed ID: 32869840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Chronic Hepatitis B in HIV-Coinfected Patients.
    Fasano M; Poliseno MC; Fiore JR; Lo Caputo S; D'Arminio Monforte A; Santantonio TA
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.
    Sun HY; Sheng WH; Tsai MS; Lee KY; Chang SY; Hung CC
    World J Gastroenterol; 2014 Oct; 20(40):14598-614. PubMed ID: 25356024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204.
    Hwang JP; Arnold KB; Unger JM; Chugh R; Tincopa MA; Loomba R; Hershman D; Ramsey SD
    Support Care Cancer; 2022 Dec; 31(1):93. PubMed ID: 36585488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent hepatitis B virus and HIV coinfections in dually humanized mice engrafted with human liver and immune system.
    Hogan G; Winer BY; Ahodantin J; Sellau J; Huang T; Douam F; Funaki M; Chiriboga L; Su L; Ploss A
    J Med Virol; 2023 Jul; 95(7):e28930. PubMed ID: 37403703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
    J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
    Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
    Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?
    Saud LRC; Chagas AL; Maccali C; Pinto PVA; Horvat N; Alencar RSSM; Tani CM; Abdala E; Carrilho FJ
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):583-588. PubMed ID: 33560682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese.
    Yang R; Gui X; Xiong Y; Gao S; Zhang Y; Deng L; Liang K; Yan Y; Rong Y
    Infection; 2011 Oct; 39(5):427-31. PubMed ID: 21713428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.